The family of actins are cytoskeletal proteins that play a critical role in a wide array of cellular processes including cell division, migration, contraction and differentiation^[@R1]--[@R4]^. Thus, altered expression of actin isoforms has been a focus in multiple physiological and pathological processes^[@R5],[@R6]^. Epithelial-mesenchymal transition (EMT), for example, is a critical biological process in cancer cell metastasis, in which epithelial cancer cells acquire de novo expression of smooth muscle α-actin (SM α-actin), a key biomarker in EMT and differentiate to a motile phenotype^[@R7]^. In wound healing and fibrosis, resident fibroblasts differentiate to the activated myofibroblasts by the virtue of expression of SM α-actin and extracellular matrix^[@R8]^. In liver fibrosis, quiescent hepatic stellate cells (HSCs) differentiate to myofibroblast-like cells, also known as hepatic myofibroblasts, through activation and acquire a number of functional phenotypes related to SM α-actin expression^[@R3],[@R9],[@R10]^.

The six different actin isoforms in mammalian cells are highly conserved and have remarkable amino acid sequence homology^[@R11],[@R12]^. Progress in understanding the functional importance of the relatively minor differences between actin isoforms has been made possible by study of specific actin isoform deficient mice. Deletion of β-actin is lethal^[@R13]^, while cytoplasmic γ-actin deficiency leads to impaired cell growth and survival^[@R14]^. SM α-actin deficiency results in a specific defect of lactation in nursing dams and decreased contractility in activated HSCs^[@R3],[@R15]^. These findings suggest that the cytoplasmic actin isoforms are essential for cell growth and survival, while the more restricted actins play a critical role in tissue specific functions.

Regulation of actin expression has been extensively studied, in particular, for the smooth muscle isoform in vascular smooth muscle cells^[@R16]^. This body of work suggests that actins are serum response factor (SRF) target genes since their promoters contain a 10-base pair *cis* element CC(A/T)6GG known as the CArG box^[@R17]^, which allows SRF binding and activates transcription. In HSCs, SM α-actin promoter activity appears to be particularly SRF binding dependent since mutation or deletion of the both CArG-B and A boxes leads to nearly complete elimination of the promoter activity^[@R18]^. In contrast, β-actin promoter activity not only requires the CArG box but also an essential CCAAT box^[@R19]^. Little is known about the mechanism underlying the regulation of cytoplasmic γ-actin. In addition to CArG box for SRF binding, SRF-induced transactivation is prominently modulated by its cofactors^[@R20]^. Myocardin, as a restricted expression pattern in cardiac and smooth muscle cells^[@R20],[@R21]^, has been demonstrated to be important SRF cofactors and play a critical role in cardiomyocytes and smooth muscle cell differentiation through activation of muscle specific genes^[@R22],[@R23]^. Interestingly, myocardin was identified in HSCs in an array, linking myocardin with SM α-actin and type 1 collagen expression during HSC activation^[@R24]^. While the molecular pathways underlying the process remains elusive.

In the current study, we explored the molecular mechanisms of actin cytoskeleton regulation by myocardin during HSC activation and hepatic myofibroblast differentiation and the effect of actin cytoskeleton alteration on extracellular matrix protein type 1 collagen expression. Our results demonstrate that myocardin induces a novel actin expression pattern through differential regulation of SM α-actin, cytoplasmic-γ-actin and β-actin isoforms, all of which compose the activated HSC's cytoskeleton and directly link it to morphological and functional properties in activated HSCs. Further, the data indicate an indirect link to the extracellular matrix protein, type 1 collagen.

MATERIALS AND METHODS {#S1}
=====================

Animal model and cell culture {#S2}
-----------------------------

Sprague Dawley (SD) male rats (400 -- 500g) were purchased from Charles' River Lab and housed in MUSCs animal facility following the NIH and the IACUC guideline. Liver fibrosis was induced by carbon tetrachloride (CCl~4~) (once a week for 4 \~ 6 weeks) as described^[@R25]^. HSCs were isolated by in situ enzymatic digestion of normal or fibrotic rat liver and purified by Accudenz (Accurate Chemicals, Westbury, NY) gradient as described^[@R18]^. Freshly isolated HSCs were cultured in standard 199OR medium containing 10% calf serum and 10% horse serum (Invitrogen, Grand Island, NY) in a 3% CO~2~ incubator at 37°C otherwise stated.

Adenovirus and cell infection {#S3}
-----------------------------

A mouse vascular form of myocardin (856 aa) and a dominant negative myocardin (635 aa, without the activation domain) were subcloned from pcDNA3.1-myocardin plasmid construct (a gift from Dr. Olson's laboratory) into a modified pDC316 shuttle vector (Microbix, Toronto) with pCMV promoter and HA ([hemagglutinin]{.ul}) tag. The resulting pDC316-HA-myocardin and pDC316-HA dominant negative myocardin plasmids were cotransfected with pBGHloxΔE1,3-cre viral plasmid into 293HEK cells to generate adenovirus-HA-myocardin (Ad-myocd) and adenovirus-HA-dominant negative myocardin (Ad-myocd-DN). [An empty pDC316 shuttle vector with pCMV promoter was cotransfected with pBGHloxΔE1,3-cre viral plasmid into 293HEK cells to generate adenovirus control (Ad-ctr).]{.ul} Viral screening and purification were performed according to manufacture's instructions (Clontech, Mountain View, CA). Fresh isolated HSCs were cultured for 2 days and then infected with adenoviral vectors (100 MOI) in standard 199OR medium for 3 days. [*In vivo* adenovirus (2.5 × 10]{.ul}^[11]{.ul}^ [pfu per rat) administration was performed via portal vein injection as described before]{.ul}^[@R26],\ [@R27]^.

Immunoblotting {#S4}
--------------

Immunoblotting was performed as described^[@R18]^. Specific signals were captured by the Syngene G-Box digital imaging system (Syngene, Frederick, MD) and quantitative data obtained from the system's software. Raw values for control samples were arbitrarily set to 1 (or 100%), and data were presented as fold-increase or percentage of the controls. Antibodies to detect SM α-actin (1A4) and β-actin (AC15), α-tubulin, and Rho kinase inhibitor Y27632 were obtained from Sigma (St. Louis, MO). Antibodies to detect cytoplasmic-γ-actin isoform (AB3265) and total actin (C4), GAPDH ([as a loading control]{.ul}) were from Millipore (Temecula, CA). Anti-type 1 collagen (COL.1) antibody was purchased from Rockland (Gilbertsville, PA). Anti-SRF, p-Smad2, total Smad2, p-Erk, and myocardin antibodies were purchased from Cell Signaling (Danvers, MA) and Novus Bio (Littleton, CO) respectively. TGFβ were purchased from Prospec-Tany TechnoGene (Ness Ziona, Israel).

Immunocytochemistry and histology {#S5}
---------------------------------

Immunofluorescence staining was performed as described^[@R15]^. Briefly, HSCs were washed with PBS twice and fixed in 4% buffered formaldehyde solution for 15 minutes. Following exposure to Triton X100 (0.5% in PBS) for 5 minutes and then with 3% BSA in PBS for 30 minutes, cells were incubated with primary antibodies at room temperature for 1 hour. After further washing with PBS, cells were incubated with secondary antibodies for 1 hour. Finally, cells were stained with DAPI (Sigma) for 15 minutes before mounting with FluorSave solution (Calbiochem, San Diego, CA). Anti- SM α-actin antibody (conjugated with Cy3) and anti-β-actin antibody (AC15) were purchased from Sigma (St. Louis, MO). Anti-cytoplasmic-γ-actin isoform (AB3265) antibody was from Millipore (Temecula, CA). Alexa Fluor 488 phalloidin, fluophor 488 donkey anti-sheep, fluophor 555 goat anti-rabbit and mouse antibodies were obtained from Life Technology (Carlsbad, CA). Images were captured with Olympus FV10i LIV confocal microscope (the Cell & Molecular Imaging Shared Resource, Hollings Cancer Center, Medical University of South Carolina) and Zeiss Axio Imager M2 (Molecular Morphology, Medical University of South Carolina). [For histologic analysis, liver tissue was fixed in 10% buffered formalin (Fisher, NJ). Picrosirius red staining was performed as before]{.ul}^[@R28]^ [and collagen content (area %) was quantitated via image-J.]{.ul}

Plasmid constructs, transfection and luciferase activity assay {#S6}
--------------------------------------------------------------

Rat SM α-actin promoter and the CArG box mutants were described before^[@R18]^. β-actin (Genbank accession number:[V01217.1](V01217.1)) and cytoplasmic-γ-actin promoters (Genbank accession number:[AC095876.6](AC095876.6)) were cloned from rat genomic DNA by PCR and DNA fragments were ligated into pGL3B luciferase reporter vector (Promega, Madison, WI). CArG and CCAAT boxes in the actin promoters were mutated using site mutagenesis kit (Agilent, Santa Clara, CA). Type 1α1 and 1α2 Collagen promoters were cloned from mouse genomic DNA and ligated into pGL3B luciferase reporter vector (Promega, Madison, WI). The constructs with deletions were created by PCR approach. SRF promoter luciferase reporter constructs were described as before^[@R18]^. All constructs were confirmed by sequencing (Genewiz, South Plainfield, NJ). The myocardin expression construct (pcDNA3.1+myocardin) was obtained from Dr. Eric Olson's laboratory. Co-transfections were performed in activated rat HSCs with lipofectamine 2000 (Invitrogen, Grand Island, NY) as described before^[@R18]^. Luciferase activity was measured with a dual-luciferase assay kit (Promega, Madison, WI). All transfection experiments were performed in triplicate and repeated twice. Relative light units (RLU) after transfection with a pGL3B reporter vector were arbitrarily set to 1 and data were presented as fold increase relative to pGL3B activity as described^[@R29]^. Primers used for cloning and site mutagenesis are listed in [Supplemental Table 1](#SD1){ref-type="supplementary-material"}.

Cell contraction assay and wound healing assay {#S7}
----------------------------------------------

Freshly isolated HSCs were cultured on collagen gels (Advanced Biomatrix, San Diego, CA) as described^[@R3]^. Cells were exposed to adenovirus (100MOI) on the second day of culture and incubated for 3 further days. Then fresh medium containing serum with or without endothelin-1 (ET-1, American peptide company, Sunnyvale, CA) was added. At specified times, gels were released from the plastic substratum, and gel area was measured as described^[@R3]^.

Cell migration was measured using a wound healing assay kit (Cell Biolabs, San Diego, CA). In brief, cells were cultured in 24-well plates containing a specific insert in each well bottom to divide cell cultures to equally. Following 2 days of culture, the insert was removed and formed a clear, sharp demarcation on the plastic substrate. Then HSCs were exposed to adenovirus (100 MOI) in standard medium. Wound closure was subsequently measured over time and the quantitated data were obtained from triplicate experiment according to manufacture's instructions.

Real time-PCR (RT-PCR) and RNase protection assay (RPA) {#S8}
-------------------------------------------------------

RNA from HSCs was isolated using Trizol reagent (Invitrogen) and 1--2 μg of total RNA was used for first-strand cDNA synthesis by SuperScript III (Invitrogen). Resulting cDNA was PCR amplified using gene specific primers ([Table S1](#SD1){ref-type="supplementary-material"}) and SYBR green supermix (BioRad, Hercules, CA) on a BioRad CFX Connect Real-Time PCR Detection System. For actin isoform RNA expression analysis, 5 μg of total RNA was hybridized with radioactive labeled gene-specific cRNA probes using an RPA III kit (Ambion, Austin, TX) ([Supplemental Figure S1](#SD1){ref-type="supplementary-material"}) as described before^[@R18]^. Specific signals for SM α-actin, cytoplasmic-γ-actin and β-actin were captured and quantitated using a phosphoimager (Syngene G-Box digital imaging system, Syngene, Frederick, MD). Control signals were arbitrarily set to 1 or 100% and data were presented as fold increase compared to controls.

Electrophoretic mobility shift assay (EMSA) {#S9}
-------------------------------------------

Nuclear extracts were prepared and EMSA was performed as described before^[@R18]^. In brief, nuclear extracts (10 μg) were incubated with^[@R32]^P-labeled DNA probes (for probe sequences, see [Supplemental materials](#SD1){ref-type="supplementary-material"}) at room temperature for 30 minutes. For supershift assays, 2 μl of anti-SRF antibody (Cell Signaling, Danvers, MA) was added to the reaction and incubated for 30 minutes at room temperature prior incubation with labeled probe. DNA-protein complexes were separated by non-denature polyacrylamide gel electrophoresis and specific signals were captured using a phosphoimager (Syngene G-Box digital imaging system (Syngene, Frederick, MD).

Statistical Analysis {#S10}
--------------------

Quantitative data were analyzed with Microsoft Excel software. Bar graphs represent mean ± SD (standard deviation). Significance (p \< 0.05) was assessed by the Student's t-test.

RESULTS {#S11}
=======

Upregulation of myocardin tightly associates with increased expression of actin cytoskeleton. {#S12}
---------------------------------------------------------------------------------------------

To explore the basic cell and molecular mechanisms underlying myocardin-mediated HSC activation and myofibroblast-like phenotype differentiation, we first examined myocardin expression in CCl~4~--induced liver fibrogenesis *in vivo*. Myocardin mRNA was significantly increased in activated HSCs from fibrotic liver compared to HSCs from normal liver ([Figure 1A](#F1){ref-type="fig"}). Next, since myocardin localizes to the nucleus and physically forms a complex with SRF and potentiates SRF activity^[@R30],[@R31]^, we examined myocardin and SRF protein levels in the nuclear extracts of HSCs from normal and fibrotic livers. We found that myocardin and SRF were upregulated ([Figure 1B](#F1){ref-type="fig"}), suggesting that both of them are required for HSC activation. Since myocardin regulates all smooth muscle specific genes^[@R32]^, we examined the correlation between myocardin and actin isoform expression. As expected, SM α-actin was dramatically upregulated (15--16 fold), and surprisingly, cytoplasmic-γ-actin was also significantly elevated (7--8 fold). [Unexpectedly, β-actin, a typical "housekeeping" gene, was also increased]{.ul} ([Figure 1C](#F1){ref-type="fig"}). Further, we examined whether the expression patterns [of these proteins in an]{.ul} *in vivo* liver injury model [recapitulated the culture-based]{.ul} *in vitro* model. Indeed, expression patterns of myocardin, SRF, SM α-actin, cytoplasmic-γ-actin and β-actin in culture-induced HSC activation ([Figure 1D, E, F](#F1){ref-type="fig"}) were similar to that *in vivo* liver injury ([Figure 1B, C](#F1){ref-type="fig"}). These data strongly suggest that HSC activation [is associated with]{.ul} upregulation of myocardin and SRF, which promote actin isoform expression and actin dynamics in response to cellular differentiation signals.

Myocardin stimulates a HSC myofibroblast-like phenotype differentiation *in vitro* and *in vivo*. {#S13}
-------------------------------------------------------------------------------------------------

To evaluate the role of myocardin in HSC activation, primary rat HSCs were used to examine bona fide biological responses to myocardin. Additionally, an adenovirus harboring a [smooth muscle]{.ul} form of myocardin (Ad-myocd) and dominant negative myocardin (Ad-myocd-DN) were used to modulate myocardin activity, since HSCs primarily express a smooth muscle form of myocardin ([Supplemental Figure S2](#SD1){ref-type="supplementary-material"}). HSCs infected with Ad-myocd virus exhibited a more prominent activated appearance - [characterized]{.ul} by an enlarged cell size and prominent lamellipodia. In contrast, HSCs infected with dominant negative myocardin had a less activated appearance, characterized by smaller cell size and less prominent cellular processes ([Figure 2A](#F2){ref-type="fig"}). [Myocardin induced prominent actin stress fibers, in particular SM α-actin stress fibers ([Figure 2B](#F2){ref-type="fig"}) and cytoplasmic-γ-actin stress fibers ([Figure 2C](#F2){ref-type="fig"}), which were thick and long in the cell cytoplasm.]{.ul} Additionally, [cytoplasmic]{.ul}-γ-actin stress fibers appeared to [be prominent in filopodia around]{.ul} the membrane ([Figure 2C](#F2){ref-type="fig"}). In contrast, inhibition of myocardin ([with the dominant negative construct]{.ul}) appeared to inhibit the activated [phenotype - leading to]{.ul} smaller and rounder cells, with stress fibers forming a thick ring (which was mainly composed of SM α-actin and [cytoplasmic]{.ul}-γ-actin stress fibers) [at]{.ul} the inside of the cell membrane and a disorganized intracellular pattern ([Figure 2B, C](#F2){ref-type="fig"}, lower panel). Dominant negative myocardin also caused corresponding changes in β-actin, [characterized]{.ul} by actin spots along thin actin stress fibers ([Figure 2D](#F2){ref-type="fig"}). Additionally, myocardin was localized in both [the]{.ul} cytoplasm and nuclei of HSCs, while dominant negative myocardin was [primarily]{.ul} localized in the nuclei of HSCs ([Figure 2E](#F2){ref-type="fig"}).

Further, we examined the effect of overexpression of myocardin in CCl~4~-induced liver fibrogenesis *in vivo* ([Figure 3](#F3){ref-type="fig"}). Since the myocardin deficient mouse is an embryonic lethal and thus could not be used to examine the effect of myocardin *in vivo*, we chose to overexpress myocardin in HSCs with an adenovirus expressing myocardin (note that we have previously demonstrated that parenteral administration of adenovirus leads to efficient viral expression in HSCs^[@R27]^). Liver injury was established by administration of CCl~4~ before administration of adenovirus ([Figure 3A, D](#F3){ref-type="fig"})^[@R27]^. In the first model, myocardin expression led to a highly activated HSC appearance and increased SM α-actin and type 1α1 mRNA expression compared to control ([Figure 3,A--C](#F3){ref-type="fig"}). In the second CCl~4~-induced liver fibrosis model, extracellular matrix protein collagen deposition was increased after myocardin overexpression (compared to control, [Figure 3, D, E](#F3){ref-type="fig"}). These data demonstrate the importance of myocardin in regulation of hepatic myofibroblast differentiation *in vitro* and *in vivo*.

Myocardin mediates functional effects in HSCs. {#S14}
----------------------------------------------

Prominent functional features of activated HSCs include enhanced contractility and [cell motility]{.ul}^[@R3]^. [Thus, we examined whether myocardin had functional effects in HSCs.]{.ul} As expected, [overexpression]{.ul} of myocardin increased [basal]{.ul} HSC contractility, while inhibition of myocardin reduced endothelin-1 (ET-1) mediated HSC contractility ([Figure 4A--C](#F4){ref-type="fig"}). [Additionally]{.ul}, inhibition of myocardin [activity]{.ul} reduced HSC migration ([Figure 4D](#F4){ref-type="fig"}), [a phenotype]{.ul} similar to SM α-actin deficient HSCs^[@R3]^. [Notably,]{.ul} exogenous expression of myocardin [had minimal effects on]{.ul} cell motility. Taken together, the data demonstrate that myocardin has important functional effects in activated HSCs.

Myocardin differentially regulates actin isoform expression. {#S15}
------------------------------------------------------------

To explore the molecular basis of myocardin mediated morphological and functional effects on HSCs, we examined actin isoform expression following exogenous expression of myocardin or dominant negative myocardin in activated HSCs. To measure the bona fide target actin isoform mRNA expression, we used [unique probes specific to]{.ul} nucleotides in the amino termini of the actins ([with]{.ul} RNase protection assay (RPA), [Supplemental Figure S1](#SD1){ref-type="supplementary-material"}). SM α-actin and [cytoplasmic]{.ul}-γ-actin mRNA levels were upregulated by myocardin (6--7 fold and almost 2-fold vs. control, respectively) ([Figure 5A, B](#F5){ref-type="fig"}). β-actin mRNA was also increased compared to the control. In contrast, inhibition of myocardin led to significant decreases in SM α-actin and [cytoplasmic]{.ul}-γ-actin mRNAs, while β-actin mRNA was only modestly affected ([Figure 5A, C](#F5){ref-type="fig"}).

Next, we examined regulation of actin [protein isoforms by myocardin]{.ul}. [Overexpression of myocardin]{.ul} caused dramatic upregulation of SM α-actin. [Cytoplasmic]{.ul}-γ-actin and β-actin were also significantly increased (7--8 fold and 0.8--1 fold vs. control, respectively), which all composed of the increased total actin ([Figure 5D, E](#F5){ref-type="fig"}). These results were similar to the actin expression patterns in activated HSCs induced by culture or *in vivo* liver injury ([Figure 1 C, E, F](#F1){ref-type="fig"}), suggesting a bona fide biological effect of myocardin on actin isoform expression. In contrast, after [blocking myocardin function (Ad-myocd-DN), both SM α-actin and cytoplasmic-γ-actin were significantly]{.ul} decreased (by 78%, 56%, respectively); β-actin was also reduced, which all together led to more than 50% reduction in the total actin ([Figure 5D, F](#F5){ref-type="fig"}). In aggregate, these data suggest that myocardin differentially regulates actin isoform expression, which appears to be primarily [via transcriptional regulation]{.ul}.

CArG box and ATTA, CCAAT boxes are specifically required for myocardin-induced differential regulation of actin isoform transcription. {#S16}
--------------------------------------------------------------------------------------------------------------------------------------

The CArG box, [found in the promoter region of many genes coding for structural proteins, has been established as the core SRF binding]{.ul} sequence^[@R16],[@R17]^. We [next]{.ul} examined whether CArG boxes in the [different]{.ul} actin promoters ([Figure 6A](#F6){ref-type="fig"}) might have differential activity in HSCs. [We found that SRF binding activity in the]{.ul} SM α-actin promoter was lower than in the cytoplasmic-γ-actin or β-actin promoter [at baseline]{.ul} ([Figure 6B](#F6){ref-type="fig"}, black columns 1 vs. 5 and 9). However, myocardin potently stimulated [SRF binding to the]{.ul} SM α-actin promoter, [which was greater]{.ul} than [for the]{.ul} cytoplasmic-γ-actin or β-actin promoter ([Figure 6B](#F6){ref-type="fig"}, open columns 2 vs. 1, 6 vs. 5 and 10 vs. 9). [Mutation]{.ul} of CArG boxes ([Figure 6A](#F6){ref-type="fig"}) in [the]{.ul} SM α-actin promoter nearly eliminated SM α-actin promoter activity and almost completely abrogated myocardin-induced promoter activity ([Figure 6B](#F6){ref-type="fig"}, columns 3 and 4). In contrast, mutation of CArG [boxes]{.ul} in cytoplasmic-γ-actin or β-actin [promoters]{.ul} had a less [prominent]{.ul} effect, particularly in the cytoplasmic-γ-actin promoter. CArG box mutation [had a substantial effect on both cytoplasmic]{.ul}-γ-actin and β-actin promoter activities with myocardin stimulation ([Figure 6B](#F6){ref-type="fig"}, columns 7 vs. 5, 8 vs. 6 and 11 vs. 9, 12 vs. 10). These data indicate that the CArG boxes in actin [promoters]{.ul} are required for basal and myocardin-induced transcriptional activation, [but that there is a differential effect for the different actin CArG boxes]{.ul}.

We further examined whether SRF binding activity could be associated with the [observed differential]{.ul} (myocardin-mediated) actin promoter activities. As expected, SRF binding activity to all [of the actin]{.ul} CArG boxes was increased in nuclear [extracts after]{.ul} expression of myocardin ([Figure 6C](#F6){ref-type="fig"}, lane 3 vs. lane 2), indicating that myocardin enhanced SRF binding activity, consistent with previous [data in]{.ul} smooth muscle cells^[@R33]^. Interestingly, SRF binding activity to [the]{.ul} CArG boxes [in the]{.ul} SM α-actin promoter [was]{.ul} significantly reduced [by a]{.ul} dominant negative myocardin [construct]{.ul} ([Figure 6C](#F6){ref-type="fig"}, panel 1 and 2; lane 4 vs. lane 2), but SRF binding activity to CArG boxes in cytoplasmic-γ-actin and β-actin promoters were [minimally affected]{.ul} ([Figure 6C](#F6){ref-type="fig"}, panel 3, 4; lane 4 vs. lane 2). We hypothesized that such differential SRF binding activity among the CArG boxes might be due to different A/T content, since CArG boxes in [the]{.ul} SM α-actin promoter [contain]{.ul} single C or G substitutions ([Figure 6A](#F6){ref-type="fig"}). [By using]{.ul} identical amounts of nuclear extract from activated HSCs ([Figure 6D](#F6){ref-type="fig"}, lower panel) and the same amount of probe harboring individual CArG box sequences ([Figure 6D](#F6){ref-type="fig"}), we found that the SM α-actin CArG-B box exhibited lower SRF binding activity ([Figure 6D](#F6){ref-type="fig"}, lane 2) than cytoplasmic β- or γ-actin CArG [boxes]{.ul} ([Figure 6D](#F6){ref-type="fig"}, lane 4). Interestingly, although the CArG boxes in cytoplasmic-γ-actin and β-actin promoters are both conserved ([Figure 6A](#F6){ref-type="fig"}), more SRF binding activity was present in the CArG box of cytoplasmic-γ-actin than in [the]{.ul} β-actin CArG box ([Figure 6D](#F6){ref-type="fig"}, lane 4 vs. 3). Taken together, these results revealed that CArG boxes with different A/T content led to differential SRF binding. [Further,]{.ul} the SM α-actin promoter [appeared to be]{.ul} more sensitive to myocardin stimulation than [the]{.ul} other two actin promoters, suggesting a reverse relationship between SRF binding and myocardin sensitivity.

Previous studies revealed that [a]{.ul} conserved ATTA box in SM α-actin promoter^[@R33]^ and [a]{.ul} CCAAT box^[@R19]^ in the cytoplasmic β-actin promoter play an important role in actin [mRNA expression]{.ul}. [Therefore we]{.ul} examined whether these boxes have functional effects on myocardin-induced promoter activity among the actin isoforms ([Figure 6E](#F6){ref-type="fig"}). Myocardin-induced SM α-actin promoter activity was prominently reduced in the ATTA box mutant construct (1.9 fold reduction) compared to the wild type construct ([Figure 6F](#F6){ref-type="fig"}, column 4 vs. 2). Similarly, the CCAAT box mutation significantly abrogated myocardin-induced cytoplasmic-γ-actin and β-actin promoter activity (4.4 and 0.9 fold reduction, respectively) ([Figure 6F](#F6){ref-type="fig"}, columns 8 vs. 6; 12 vs. 10). These results [suggest]{.ul} that the ATTA (SM α-actin promoter) and CCAAT [boxes]{.ul} (cytoplasmic-γ-actin and β-actin promoter) are required for [full]{.ul} myocardin-mediated transactivation.

Next, we examined whether the ATTA box was able to stimulate cytoplasmic-γ-actin and β-actin promoter activity since it appeared to be critical for myocardin-induced promoter activity in the SM α-actin promoter ([Figure 6G](#F6){ref-type="fig"}). Interestingly, substitution of the CCAAT box in the cytoplasmic-γ-actin promoter with the ATTA box did not change the promoter activity as that in the CCAAT box mutant construct ([Figure 6F](#F6){ref-type="fig"}), but such substitution prominently restored myocardin-induced cytoplasmic-γ-actin promoter activity ([Figure 6H](#F6){ref-type="fig"}, column 8 vs. 6). Similar to [the]{.ul} β-actin promoter, replacement CCAAT box with the ATTA box also significantly restored myocardin-mediated promoter activity ([Figure 5H](#F5){ref-type="fig"}, column 12 vs. 10). In contrast, substitution of the ATTA box in [the]{.ul} SM α-actin promoter with [a]{.ul} CCAAT box led to the same result as that in the ATTA box mutant SM α-actin promoter construct ([Figure 6H](#F6){ref-type="fig"}, column 4 vs. 2). These results suggest that the ATTA box is an indispensable element in SM α-actin promoter ([i.e. to]{.ul} mediate myocardin-induced full promoter activity). However, the CCAAT box is [specifically]{.ul} required for myocardin-induced cytoplasmic-γ-actin and β-actin actin promoter activity.

Myocardin mediates type 1 collagen expression in HSCs. {#S17}
------------------------------------------------------

Type 1 collagen expression is regulated via multiple factors, including MRTF/A^[@R34]^. Myocardin, as a major member in [this]{.ul} family^[@R35]^, may also play a role in regulation of type 1 collagen expression in HSCs. Indeed, type 1 collagen expression was increased by [wild type]{.ul} myocardin but decreased by dominant negative myocardin ([Fig. 7A](#F7){ref-type="fig"}). To explore the molecular pathways underlying this process, we examined the effect of myocardin on TGFβ-induced type 1 collagen expression. As expected, TGFβ enhanced type 1 collagen expression in control HSCs. SM α-actin and cytoplasmic γ-actin were also upregulated by TGFβ. However, TGFβ-induced type 1 collagen expression was abrogated by dominant negative myocardin, which was accompanied by reduced expression of actin isoforms ([Fig. 7B](#F7){ref-type="fig"}). Additionally, myocardin prominently enhanced Smad2 phosphorylation (p-Smad2), but dominant negative myocardin did not significantly reduce Smad2 phosphorylation compared to the control ([Fig. 7C](#F7){ref-type="fig"}). The results suggest that myocardin is able to stimulate TGFβ signaling through myocardin-mediated actin expression, thereby regulates type 1 collagen expression^[@R36]^.

[We next]{.ul} examined the role of myocardin in endothelin-1 (ET-1)-mediated type 1 collagen expression, since ET-1 also increases type 1 collagen expression (via Erk and AP-1 pathways^[@R37]^). Similar to TGFβ, ET-1 upregulated type 1 collagen expression, accompanied by increased expression of SM α-actin, cytoplasmic γ-actin, SRF and Erk-phosphorylation. [These]{.ul} effects were prominently inhibited by dominant negative myocardin ([Fig. 7D](#F7){ref-type="fig"}), suggesting that myocardin is able to regulate type 1 collagen expression via endothelin-1-mediated actin cytoskeleton proteins, SRF and Erk pathways.

Finally, since Rho signaling mediates actin stress fiber formation and disruption of Rho pathway suppresses collagen accumulation in activated HSCs^[@R38]^, we examined the effect of Y-27632, a specific Rho kinase inhibitor, on myocardin-induced type 1 collagen expression. As expected, Y-27632 disrupted actin stress fibers and led to a disorganized actin cytoskeleton in control HSCs ([Fig. 7E](#F7){ref-type="fig"}). [The effect]{.ul} of Y27632 was abrogated by exogenous expression of myocardin ([Fig. 7E](#F7){ref-type="fig"}, lower panel). [Type]{.ul} 1 collagen expression was significantly decreased by Y-27632 in control HSCs, but myocardin [rescued]{.ul} the effect of Y-27632 ([Fig. 7F](#F7){ref-type="fig"}, top panel). Simultaneously, Rho inhibition resulted in decreased SM α-actin and cytoplasmic γ-actin [expression, and was also]{.ul} rescued by myocardin. These findings provide further support for the concept that myocardin mediates actin and actin dependent regulation of type 1 collagen expression.

Myocardin targets SRF expression and stimulates type 1 collagen transcription. {#S18}
------------------------------------------------------------------------------

In activated HSCs, since the SRF gene promoter has CArG boxes^[@R18],[@R39]^, [and since upregulation of myocardin coincided with increased SRF expression ([Fig. 1B, D](#F1){ref-type="fig"}), we postulated that myocardin might directly regulate SRF]{.ul}. Indeed, exogenous expression of myocardin increased both SRF mRNA and SRF protein levels in HSCs, while dominant negative myocardin decreased SRF mRNA and protein expression ([Fig. 8A, B](#F8){ref-type="fig"}). To further examine the transcriptional regulation of SRF, wild type (WT) and CArG mutant SRF promoter constructs were cotransfected with myocardin expression plasmid in activated HSCs^[@R18]^. Myocardin dramatically upregulated SRF promoter activity (8.8 fold increase), while myocardin failed to fully elevate SRF promoter activity in the CArG box mutant SRF promoter construct ([Fig. 8C](#F8){ref-type="fig"}). The data suggest that myocardin positively stimulates [an]{.ul} SRF autoregulatory loop.

Since the type 1α1 and 1α2 collagen promoters also contain [a]{.ul} CArG box^[@R40]^, [we also examined whether myocardin might potentiate type 1α1 and 1α2 collagen promoter activity. Exogenous]{.ul} expression of myocardin led to a significant increase in both type 1α1 and 1α2 collagen promoter activities ([Fig. 8D, E](#F8){ref-type="fig"}), while the myocardin-induced effect was inhibited by mutation of the CArG box in both promoters. These data suggest that myocardin [may]{.ul} directly activate type 1α1 and 1α2 collagen transcription via SRF.

DISCUSSION {#S19}
==========

A defining property of the HSC to myofibroblast differentiation is the *de novo* expression of SM α-actin, which associates with multiple functional features of activated HSCs^[@R9]^, although the fundamental molecular mechanisms underlying hepatic myofibroblast differentiation remain poorly understood. In the present study, our results demonstrate that myocardin is an important factor to promote HSC activation process. Myocardin positively targets SRF autoregulatory loop to increase SRF expression. Myocardin and SRF appear to serve as a core regulatory platform to differentially regulate actin isoform expression through myocardin's different sensitivity to differential SRF binding activity on the CArG boxes as well as the ATTA and CCAAT boxes in different actin promoters. Myocardin-induced upregulation of actin expression not only contributes to morphological and functional features in activated HSCs, but also indirectly regulates type 1 collagen expression ([Fig. 8F](#F8){ref-type="fig"}).

HSC activation toward myofibroblast differentiation is a complicated molecular process in which multiple factors are involved, including MRTF/A^[@R34]^ and myocardin ([Fig. 1](#F1){ref-type="fig"}). Our results suggest that HSCs may have unique myofibroblastic features since HSCs contain vitamin A lipid droplets^[@R10]^ and express myocardin ([Fig. 1](#F1){ref-type="fig"})^[@R24],\ [@R41]^, which are different from the myofibroblasts of other tissue sources such as myofibroblasts in kidney and lung fibrosis^[@R42],\ [@R43]^, suggesting that different mechanisms may exist among different tissue types during wound healing process. Myocardin is located primarily in the nucleus ([Fig. 2](#F2){ref-type="fig"})^[@R35]^ and readily activates gene transcription via interaction with SRF. In contrast, MRTF/A is an actin binding protein and its nuclear translocation requires the release from actin binding in response to serum stimulation and other signals that promote actin polymerization^[@R20]^. It is likely that myocardin stimulates HSC activation via upregulation of smooth muscle specific genes, while MRTF/A may potentiate the effect of myocardin in response to increased actin polymerization during HSC activation and myofibroblast differentiation.

SM α-actin is a well-known molecular marker for myofibroblast differentiation^[@R8]--[@R10]^. Our results revealed that in addition to SM α-actin, cytoplasmic γ-actin was significantly upregulated in activated HSCs ([Fig. 1](#F1){ref-type="fig"}). The finding suggests that cytoplasmic γ-actin may also play an important role in promotion of HSC activation, which was not reported in previous studies regarding to HSC activation. Noticeably, cytoplasmic β-actin was also increased, which together with SM α-actin and cytoplasmic γ-actin consisted of the total actin pool in activated HSCs. We also found that myocardin enhanced actin stress fiber formation ([Fig. 2](#F2){ref-type="fig"}), presumably due to increased RhoA expression induced by myocardin ([Fig. 7F](#F7){ref-type="fig"}). Taken together, increased expression of actin isoforms and actin stress fibers are likely critical for morphological and functional attributes of hepatic myofibroblasts ([Fig. 2](#F2){ref-type="fig"}, [3](#F3){ref-type="fig"}, [4](#F4){ref-type="fig"}).

The molecular mechanism underlying differential regulation of the actin isoforms during HSC activation remains poorly understood. Our results revealed that an opposite phenomenon between myocardin-induced actin promoter activity and the SRF binding activity to the CArG box of the actin promoters − the higher promoter activity was induced by myocardin with the lower SRF binding activity. The nature under this phenomenon was largely due to the A/T content and maybe the ratio of A to T in the CArG boxes. Our findings were consistent with a previous study in smooth muscle cells^[@R44]^, in which the conserved c-fos CArG box had more SRF binding activity than the CArG boxes of SM α-actin promoter, while myocardin-induced promoter activity was prominently reduced in the CArG boxes of SM α-actin promoter with c-fos CArG box substitution. Noticeably, our results also revealed that conserved *cis* elements - ATTA in the SM α-actin promoter and CCAAT box in the cytoplasmic γ-/β-actin actin promoters mediated myocardin-induced actin promoter activity since mutation of these conserved elements prominently damped myocardin-induced promoter activity in all three actin promoter activity ([Fig. 6E, F](#F6){ref-type="fig"}). Thus, the CArG-A and B boxes as well as the ATTA box provided myocardin-induced complete SM α-actin promoter activity. Unlike SM α-actin as a myocardin regulatory gene was reported in previous studies^[@R32]^, myocardin-induced upregulation of cytoplasmic γ-actin and β-actin were not previously described. Our results showed that the CCAAT box was likely more important than the CArG box for cytoplasmic γ-actin promoter activity; while the CArG box appeared to be more important than the CCAAT box for β-actin promoter activity ([Fig. 6B, E](#F6){ref-type="fig"}). Interestingly, myocardin-induced promoter activity between cytoplasmic γ-actin and β-actin promoters was similar ([Fig. 6B](#F6){ref-type="fig"}), but more prominently increased expression of cytoplasmic γ-actin mRNA and protein was observed compared to β-actin ([Fig. 1](#F1){ref-type="fig"}, [5](#F5){ref-type="fig"}). Our data highlight the complicated nature of myocardin-induced regulation of actin isoforms and further raise the possibility that posttranscriptional regulation might be important in actin isoform expression in activated HSCs.

Previous investigation revealed that MRTF/A was involved in regulation of type 1 collagen expression in liver wound healing^[@R34]^. Our results demonstrated that myocardin also plays an important role in regulation of type 1 collagen expression in activated HSCs [*in vitro* ([Fig. 7](#F7){ref-type="fig"}) and *in vivo* ([Fig. 3](#F3){ref-type="fig"}).]{.ul} TGFβ signaling is critical to mediate type 1 collagen expression in various fibrotic conditions^[@R45]^. Unlike MRTF/A, which did not increase p-Smad2^[@R46]^, our data revealed that myocardin prominently elevated p-Smad2 level ([Fig. 7C](#F7){ref-type="fig"}), suggesting that myocardin was able to signal to the TGFβ pathway. Notably, a dominant negative myocardin decreased type 1 collagen expression and all three actin isoforms without an effect on p-Smad2, suggesting an indirect effect of TGFβ signaling through myocardin-mediated actin expression ([Fig. 7B, C](#F7){ref-type="fig"}). Furthermore, our results suggested that myocardin was also able to affect ET-1 signaling via regulating Erk phosphorylation and SRF expression ([Fig. 7D](#F7){ref-type="fig"}), which is another important pathway in type 1 collagen expression since COL1α2 promoter has both AP-1 and SRF binding sites^[@R47]^.

The Rho pathway plays an important role in actin polymerization^[@R5],[@R36]^. Our results indicated that myocardin stimulates RhoA expression ([Fig. 7F](#F7){ref-type="fig"}), which is likely the molecular mechanism for myocardin-induced actin stress fiber formation ([Fig. 2](#F2){ref-type="fig"}, [7E](#F7){ref-type="fig"}) and functional features such as enhanced contractility in HSCs ([Fig. 4](#F4){ref-type="fig"})^[@R36]^. Indeed, basal Rho activity was required to maintain a normal actin dynamics and type 1 collagen expression, which was documented by suppression of Rho signaling with Y27632 ([Fig. 7E, F](#F7){ref-type="fig"}). However, exogenous expression of myocardin upregulated type 1 collagen production and all actin isoforms as well as RhoA levels in presence of Y27632, suggesting a feedback pathway from myocardin to RhoA via actin and actin polymerization^[@R36]^. It is likely that myocardin-induced Rho/actin signals may be resulted from heterodimerization with MRTF-A through its conserved leucine zipper (LZ) domain at least in part^[@R20]^ since HSCs express both myocardin and MRTF-A.

Additionally, our results showed that myocardin was able to directly regulate type lα1 and 1α2 collagen transactivation via CArG boxes in the promoters ([Fig. 8D, E](#F8){ref-type="fig"}). Although myocardin, as an SRF cofactor, was previously reported to regulate SRF target genes^[@R23],[@R32]^, our results for the first time showed that myocardin was able to regulate SRF expression ([Fig. 8A,B](#F8){ref-type="fig"}), which provided a positive feed back regulatory loop from myocardin to SRF, and SRF to SRF target genes ([Fig. 8F](#F8){ref-type="fig"}).

In summary, we have demonstrated that myocardin promotes HSC activation and myofibroblast differentiation. The CArG box, together with ATTA and/or CCAAT boxes, in the actin promoters primarily mediate myocardin-induced differential expression of actin isoforms, which make up the activated HSC cytoskeleton. We further show that myocardin also stimulates type 1 collagen transcription, enhances SRF expression, which appears to be a critical mechanism to rapidly enrich SRF expression in activated HSCs. Thus, myocardin is responsible for morphological and functional changes that occur during HSC activation and myofibroblast differentiation, and raise the possibility that this pathway could be targeted therapeutically.
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HSC

:   hepatic stellate cell

SM α-actin

:   smooth muscle α-actin

Cyto-γ-actin

:   cytoplasmic gamma actin

Col.1

:   type 1 collagen

Myocd

:   myocardin

SRF

:   serum response factor
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Ad-ctr
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:   dominant negative
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:   transformation growth factor beta

ET-1

:   endothelin-1

RhoA

:   Ras homolog gene family, member A

Smad2

:   Similarity to the Drosophila gene Mothers Against Decapentaplegic (Mad)2

Erk

:   extracellular-signal-regulated kinase

AP-1

:   activator protein 1

RPA

:   RNase protection assay

CCl~4~

:   carbon tetrachloride

EMSA

:   electrophoretic mobility shift assay

RT-PCR

:   real-time PCR

![Myocardin is upregulated during HSC activation *in vivo* and *in vitro*. HSCs were isolated and in Methods, and in (A), total RNA from freshly isolated HSCs from normal (NL) and fibrotic rat liver (CCl~4~) was extracted and subjected to RT-PCR to measure myocardin mRNA (n=3, \* p \< 0.01 for NL vs. CCl~4~). (B) Myocardin and SRF protein levels were measured using nuclear extracts (NE) from normal (NL) and fibrotic rat liver HSCs (CCl~4~) (n=3, \* p \< 0.05 for NL vs. CCl~4~). (C) Actin isoform protein profiles were measured in whole cell lysates from normal (NL) or fibrotic rat liver HSCs (CCl~4~). (D) HSCs from normal liver were isolated and grown in culture as in methods and myocardin and SRF levels were measured in nuclear extracts; whole cell lysates were used to assess complete actin isoform profiles (E), and quantitative data are shown graphically (F). β-actin was used as a loading control (an additional Coomassie blue stain is shown in [Figure S3](#SD1){ref-type="supplementary-material"}). Representative immunoblots from 3 independent experiments were shown.](nihms-890808-f0001){#F1}

![Myocardin induces morphological changes in activated HSCs. (A) HSCs were exposed to adenoviruses (Ad-control (Ad-ctr), Ad-myocd and Ad-myocd-DN, all at 100 MOI) for 3 days and then incubated at 0.5% serum medium for 2 days. Representative images from 3 independent experiments are shown. (B, C, D, E) Cells were grown on glass cover slips and exposed to adenovirus as in (A) and subjected to immunofluorescence labeling as in Methods. Representative images from 3 independent experiments are shown. The scale bar represents 100 μm.](nihms-890808-f0002){#F2}

![Overexpression of myocardin promotes HSC myofibroblast differentiation and liver fibrosis. (A) A schematic map for overexpression of myocardin with 4 doses of CCl~4~. 5 days after the final dose of CCl~4,~ HSCs were isolated and cultured overnight; representative phase contrast images are shown (arrow indicates an activated HSC). (B, C) Total RNA was extracted from the same cells and RT-PCR was performed to detect SM α-actin and Col.1α1 mRNA (n=3, p \< 0.01 for Ad-control (Ad-ctr) vs. Ad-myocd). (D) A schematic map for overexpression of myocardin with 6 doses of CCl~4~. 5 days after the final CCl~4~ dose, whole liver tissues were harvested and subjected to picrosirius red staining as in Methods. Quantitative data is shown graphically (n=3 \~ 4, p \< 0.05 for Ad-control (Ad-ctr) vs. Ad-myocd). The scale bar represents 100 μm.](nihms-890808-f0003){#F3}

![Myocardin-mediated functional effects. HSCs were isolated and grown on collagen lattices for 2 days and exposed to adenovirus as indicated for 3 days. Lattice contraction was as in Methods and images were taken 12 hours after gel lattice release; (A) 10% serum and 20 nM ET-1 were used as positive controls and 0.5% serum as a negative control. A representative image from 3 independent experiments is shown. In (B), quantitative data are presented graphically (the stronger the contraction, the smaller the gel area. n=3, \* p \< 0.05 for Ad-control (Ad-ctr) vs. Ad-myocd, 10% serum and 20nM ET-1, respectively). (C) Cells were isolated, grown in 0.5% serum containing medium, and exposed to different concentrations of ET-1 as indicated at the time of lattice release; images were taken after gel lattice release (6 hours and a representative image from 3 independent experiments is shown). In the panel below the image, quantitative data are shown (n=3, \* p \< 0.05 for Ad-control (Ad-ctr) vs. Ad-myocd-DN). (D) HSCs were grown in a 24-well wound healing assay plate for 2 days and then exposed to the indicated adenovirus at the same time as application of the scratch wound (images were taken after further 3 days of culture; representative images from 3 independent experiments are shown. In the graph below the images, the area of wound closure was measured as in Methods and quantitative data are shown graphically (n=3, \* p \< 0.05 for Ad-control (Ad-ctr) vs. Ad-myocd-DN).](nihms-890808-f0004){#F4}

![Myocardin induces differential expression of actin isoforms. HSCs were isolated as above and exposed to adenovirus as indicated for 3 days and then incubated in 0.5% serum medium for 2 days. (A) Actin isoform mRNA profiles were assessed by RNase protection assay (RPA). Representative images from 3 independent experiments are shown. (B) Quantitative data depicting changes in actin isoform mRNA expression induced by myocardin, or dominant negative myocardin (C) are depicted graphically. (D) Whole HSC lysates were subjected to immunoblotting to analyze actin isoform profiles (representative immunoblots from 3 independent experiments are shown) and (E) quantitative data depicting changes in actin isoform expression induced by myocardin, or dominant negative myocardin (F) are presented graphically. (n=4, \* p \< 0.05 for Ad-control (Ad-ctr) vs. Ad-myocd; \# p \< 0.05 for Ad-control vs. Ad-myocd-DN).](nihms-890808-f0005){#F5}

![Myocardin-induced differential regulation of actin isoforms is CArG box and ATTA, CCAAT box dependent. (A) CArG box sequences from rat SM α-actin, cytoplasmic-γ-actin (Cyto-γ-actin) and β-actin promoters are aligned. Site mutations are shown in bold letters (CC in CArG boxes were replaced by TT). (B) Activated HSCs were cotransfected with luciferase reporter constructs containing wild type or the CArG box mutation as in (A) and a myocardin expression plasmid (Myocd) or empty vector. Cells were harvested 2 days later to detect for promoter activity. (C) After growth for 2 days after isolation, HSCs were exposed to the indicated adenoviral vectors for 3 days and 2 days later, they were subjected to EMSA to measure the effect of myocardin on SRF binding activity. SRF binding and supershifted bands are highlighted by arrows (lane 1, 2, 5, 8: nuclear extracts from HSCs infected with Ad-control virus; lane 3, 6, 9: nuclear extracts from HSCs infected with Ad-myocd virus; lane 4, 7, 10: nuclear extracts from HSCs infected with Ad-myocd-DN virus). Representative data from 3 independent experiments are shown. (D) EMSA was performed using nuclear extracts (10 μg) from activated HSCs and the same amount of different actin CArG box probes (1 × 10^5^ cpm) as indicated. SRF binding and supershifted complexes were indicated by arrows (upper panel). Nuclear extracts were probed by anti-SRF antibody as loading control (bottom panel). Representative data from 3 independent experiments are shown. (E) A schematic diagram of wild type and mutant actin isoform promoters is shown (mutated nucleotides were indicated below the consensus sequences); (F) luciferase assays were performed as in (B). (G) A schematic diagram of exchanged elements (ATTA and CCAAT boxes) among SM α-actin, cytoplasmic-γ-actin (cyto-γ-actin) and β-actin promoters is shown; (H) luciferase activity assay was performed as in (B). (n=3, \* p \< 0.01 for wild plasmid + empty vector vs. wild plasmid + myocardin; n=3, \# p \< 0.05 for wild plasmid + empty vector vs. mutant plasmid + empty vector; n=3, \*\* p \< 0.05 for wild plasmid + myocardin vs. mutant plasmid + myocardin).](nihms-890808-f0006){#F6}

![Myocardin modulates type 1 collagen expression. (A) HSCs were exposed to adenoviruses as indicated for 3 days and then incubated in 0.5% serum medium for 2 further days. Type 1 collagen (Col.1) was measured by immunoblotting and quantitative data are shown (n=3, \* p \< 0.01 for Ad-control (Ad-ctr) vs. Ad-myocd; \# p \< 0.05 for Ad-ctr vs. Ad-myocd-DN). (B) HSCs were exposed to Ad-control or Ad-myocd-DN for 3 days and then incubated in 0.5% serum medium with or without TGFβ (10 μg) for 2 further days. Type 1 collagen and actin isoform profiling were performed by immunoblotting. Representative images from 3 independent experiments were shown and quantitative data are shown in the graph to the right (n=3, \* p \< 0.05 for Ad-control (Ad-ctr) vs. Ad-ctr + TGFβ; \#p \< 0.05 for Ad-ctr vs. Ad-myocd-DN with or without TGFβ). (C) HSCs were as in (B); HSCs were exposed to TGFβ (10 μg) for 0, 1, and 3 hours, respectively. Whole cell lysates were assayed for phospho-Smad2 (p-Smad2) and total Smad2 as indicated. Representative immunoblots from 3 independent experiments are shown. Quantitative data are shown in the graph below. (D) HSCs were as in (B), and were exposed to ET-1 (20 nM) for 2 days; cell lysates were assayed for p-Erk, SRF, Col.1 and actin isoform by immunoblotting; representative images from 3 independent experiments are shown and quantitative data are shown in the graph to the right (n=3, \* p \< 0.05 for Ad-control (Ad-ctr) vs. Ad-ctr + ET-1; \#p \< 0.05 for Ad-ctr vs. Ad-myocd-DN with or without ET-1). (E, F) HSCs were isolated and grown on either glass cover slips as in [Figure (2B)](#F2){ref-type="fig"} or standard culture dishes as above. Following virus infection for 3 days, cells were incubated in 0.5% serum medium with or without Y27632 (10 μM) for 1 day. Cells on glass cover slips were fixed and immunostained as in Methods and whole cell lysates from the same cell preparations were subjected to immunoblotting to detect type 1 collagen, RhoA and actin isoforms (left panel). Representative images from 3 independent experiments are shown and quantitative data are shown in the graph to the right (n=3, \* p \< 0.05 for Ad-control (Ad-ctr) vs. Ad-ctr with Y27632; \# p \< 0.05 for Ad-ctr vs. Ad-myocd with or without Y27632).](nihms-890808-f0007){#F7}

![Myocardin activates SRF and type 1 collagen transcription via CArG boxes in actin promoters. HSCs were cultured and infected with adenoviruses as in [Figure 7A](#F7){ref-type="fig"}. (A) SRF mRNA expression was measured by RT-PCR and (B) SRF was measured by immunoblotting; representative images from 3 independent experiments are shown and quantitative data are shown in the graph to the right (n=5, \* p \< 0.01 for Ad-control (Ad-ctr) vs. Ad-myocd; \# p \< 0.05 for Ad-ctr vs. Ad-myocd-DN). (C) Activated HSCs were cotransfected with a wild type (WT) SRF promoter (SRFproWT) or CArG box mutant SRF promoter (SRFproMuSRE) and a myocardin expression plasmid (myocd) as in [Fig. 6B](#F6){ref-type="fig"}. (D, E) Activated HSCs were cotransfected with wild type 1α1 and 1α2 collagen promoters (Col.1α1proWT, Col.1α2proWT) or CArG box mutant type 1α1 and 2 collagen promoters (Col.1α1proMuSRE, Col.1α2proMuSRE) and a myocardin expression plasmid as in [Fig. 6B](#F6){ref-type="fig"}. Quantitative data are depicted graphically (n=3, \* p \< 0.01 for WT construct with empty vector vs. with myocardin expression plasmid; \#p \< 0.01 for WT construct with myocardin expression plasmid vs. SRE mutant construct with a myocardin expression plasmid). (F) A schematic diagram providing a conceptual overview of myocardin-mediated hepatic stellate cell activation and myofibroblast differentiation is shown.](nihms-890808-f0008){#F8}
